Quality of Life of Patients With Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period With Targeted Drugs

Üroonkoloji Bülteni
doi 10.4274/uob.460
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galenos Yayinevi

Related search

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Interferon-Alfa in the Treatment of Patients With Inoperable Locally Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review

Canadian Urological Association Journal
Urology
2013English

Disparities in the Treatment of Patients With IL-2 for Metastatic Renal Cell Carcinoma

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2010English

Patients' Quality of Life During Treatment With Cytostatic Drugs in Hematologic Cancers

Annales Academiae Medicae Silesiensis
2016English

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies

2013English

Prognosis of Patients With Metastatic Renal Cell Carcinoma and Pancreatic Metastases

BJU International
Urology
2015English

Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy